In vitro β-catenin attenuation by a mefloquine-loaded core–shell nano emulsion strategy to suppress liver cancer cells

Liver cancer, with 800 000 new cases annually, is driven by Wnt/β-catenin pathway mutations in over 80% of cases. This study aims to develop a novel strategy to target this pathway, inhibit cancer cell growth and downregulate oncogenic gene expression.